Brazilian Journal of Infectious Diseases

Scope & Guideline

Elevating the discourse on infectious diseases globally.

Introduction

Welcome to the Brazilian Journal of Infectious Diseases information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Brazilian Journal of Infectious Diseases, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1413-8670
PublisherELSEVIER BRAZIL
Support Open AccessYes
CountryBrazil
TypeJournal
Convergefrom 2000 to 2024
AbbreviationBRAZ J INFECT DIS / Braz. J. Infect. Dis.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressR SETE SETEMBRO, 111-16, RIO DE JANEIRO RJ 20050-006, BRAZIL

Aims and Scopes

The Brazilian Journal of Infectious Diseases is dedicated to advancing knowledge in the field of infectious diseases through rigorous research and comprehensive reviews. It covers a wide range of topics related to epidemiology, treatment, prevention, and the clinical management of infectious diseases, particularly within the Brazilian context.
  1. Epidemiology of Infectious Diseases:
    Focuses on studies that analyze the distribution and determinants of infectious diseases, highlighting outbreaks, endemic patterns, and public health implications in Brazil.
  2. Clinical Management and Treatment Strategies:
    Explores various clinical approaches to managing infectious diseases, including pharmacological treatments, diagnostic methods, and therapeutic protocols.
  3. Microbiology and Pathogen Studies:
    Covers research on the microbiological aspects of infectious diseases, including pathogen identification, resistance patterns, and molecular diagnostics.
  4. Vaccine Research and Immunization Practices:
    Examines the development, efficacy, and public health impact of vaccines, particularly in response to emerging infectious diseases like COVID-19.
  5. Antimicrobial Resistance:
    Addresses the growing concern of antimicrobial resistance through research on resistance mechanisms, surveillance studies, and stewardship programs.
  6. Public Health and Policy:
    Investigates the intersection of infectious diseases with health policies, focusing on prevention strategies, healthcare access, and community health initiatives.
  7. Infection Control and Prevention:
    Research on strategies for infection control in healthcare settings, including studies on healthcare-associated infections and best practices.
The Brazilian Journal of Infectious Diseases has shown a dynamic response to emerging health crises, with several themes gaining prominence in recent years, particularly in light of the global COVID-19 pandemic.
  1. COVID-19 Research:
    A significant increase in studies related to COVID-19, covering aspects such as epidemiology, treatment outcomes, vaccine efficacy, and public health responses, reflecting the urgency of the pandemic.
  2. Arbovirus Studies:
    Emerging interest in arboviruses, particularly in Brazil, with a focus on detection methods, public health implications, and epidemiological patterns, indicating a response to rising cases of diseases like Dengue and Chikungunya.
  3. Molecular Diagnostics and Genomics:
    A trend towards utilizing advanced molecular techniques for diagnosing infectious diseases, emphasizing the need for rapid and accurate detection methods in clinical settings.
  4. Mental Health Impacts of Infectious Diseases:
    Growing research focus on the psychological effects of infectious diseases, including anxiety and quality of life impacts among patients and healthcare workers during the pandemic.
  5. Antimicrobial Stewardship Programs:
    An increased emphasis on strategies to combat antimicrobial resistance, with research exploring effective stewardship practices in both hospital and community settings.

Declining or Waning

As the field evolves, certain themes within the Brazilian Journal of Infectious Diseases are becoming less prominent. This decline may reflect shifting research priorities or emerging health challenges.
  1. Tuberculosis Research:
    While tuberculosis remains a critical public health issue, recent publications suggest a decreasing focus on this area, possibly due to a shift towards more pressing infectious diseases such as COVID-19.
  2. HIV/AIDS Studies:
    Although still relevant, the frequency of new research specifically addressing HIV/AIDS has waned, possibly as a result of advancements in treatment and prevention overshadowing ongoing basic research.
  3. Leprosy Research:
    Research on leprosy has seen a decline in volume, reflecting a broader public health focus on more prevalent infectious diseases, despite the continued importance of managing and understanding this condition.
  4. Zoonotic Diseases:
    There is a noticeable reduction in the exploration of zoonotic diseases, indicating a potential shift in priorities towards viral infections that have immediate public health implications.

Similar Journals

CLINICAL MICROBIOLOGY AND INFECTION

Championing Discoveries in Infectious Disease Management
Publisher: ELSEVIER SCI LTDISSN: 1198-743XFrequency: 12 issues/year

CLINICAL MICROBIOLOGY AND INFECTION is a leading journal published by Elsevier Science Ltd, dedicated to advancing the field of infectious diseases and clinical microbiology. With its ISSN 1198-743X and E-ISSN 1469-0691, this esteemed journal has maintained its influential presence since 1995, showcasing high-impact research that addresses critical issues in the diagnosis, treatment, and prevention of infections. Ranked in the Q1 quartile for Infectious Diseases, Medicine (miscellaneous), and Microbiology (medical) categories, and boasting impressive Scopus rankings of #12 and #7 respectively, it sits at the forefront of scientific inquiry in these disciplines. Although it is not an Open Access journal, it provides comprehensive access options for institutions and individuals, ensuring the dissemination of vital research findings. As the field of clinical microbiology continues to evolve, CLINICAL MICROBIOLOGY AND INFECTION remains an essential resource for researchers, clinicians, and students aiming to stay informed on the latest developments and breakthroughs in understanding infectious diseases.

Infektsiya i Immunitet

Innovating insights into disease prevention and immune response.
Publisher: SANKT-PETERSBURG-NIIEM IMENI PASTERAISSN: 2220-7619Frequency: 4 issues/year

Infektsiya i Immunitet, published by the esteemed SANKT-PETERSBURG-NIIEM IMENI PASTERA, is a prominent open access journal that has been disseminating vital research findings since 2011. Focusing on the fields of immunology and infectious diseases, this journal serves as a critical platform for scholars, professionals, and students in the Russian Federation and beyond. With an ISSN of 2220-7619 and an E-ISSN of 2313-7398, it currently holds a Q4 ranking in 2023 for both Immunology and Infectious Diseases, along with notable quartile standings in related fields. Despite its emerging status, Infektsiya i Immunitet provides valuable insights and contributes to the growing discourse on immunity and infection prevention strategies, making it an essential resource for those invested in advancing knowledge and enhancing public health outcomes. Researchers can conveniently access its wealth of articles and studies that bridge theoretical understanding and practical implications in their respective domains.

AMERICAN JOURNAL OF INFECTION CONTROL

Advancing infection prevention for a healthier tomorrow.
Publisher: MOSBY-ELSEVIERISSN: 0196-6553Frequency: 10 issues/year

The American Journal of Infection Control is a leading peer-reviewed publication dedicated to advancing the field of infection prevention and control. Published by Mosby-Elsevier, this journal has been a crucial resource since its inception in 1980, focusing on the intersection of infectious diseases, public health, and health policy. As of 2023, it holds an impressive Q1 ranking in both Health Policy and Public Health, Environmental and Occupational Health, while also achieving Q2 rankings in Epidemiology and Infectious Diseases. With an increasing impact factor and a strong reputation reflected in its Scopus rankings, the journal appeals to researchers, health professionals, and students committed to preventing the spread of infections and enhancing healthcare safety. Although it does not currently offer Open Access, the journal ensures broad dissemination of its vital research through various subscription options. By fostering interdisciplinary collaboration and evidence-based practices, the American Journal of Infection Control plays a pivotal role in shaping effective infection control policies and practices worldwide.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY

Transforming Knowledge into Action for Infection Control
Publisher: CAMBRIDGE UNIV PRESSISSN: 0899-823XFrequency: 12 issues/year

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, published by Cambridge University Press, is a leading academic journal specializing in the critical fields of epidemiology, infectious diseases, and medical microbiology. With a history of publication dating back to 1988 and an expected continuation through 2024, the journal has established itself as a pivotal resource for researchers, healthcare professionals, and students alike. The journal's impact is reflected in its impressive rankings, positioning it in the second quartile for Epidemiology and the first quartile for both Infectious Diseases and Medical Microbiology as of 2023. This esteemed journal is dedicated to the dissemination of high-quality research that informs best practices in infection control and enhances patient safety across healthcare settings. Although access to its content is not open, the rigorous peer-review process ensures that all published articles contribute significantly to the body of knowledge in these vital areas. With a commitment to bridging the gap between research and practice, INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY remains an essential publication for those committed to the advancement of public health and the science of infection prevention.

Annals of Clinical Microbiology and Antimicrobials

Uniting global voices in the battle against infections.
Publisher: BMCISSN: Frequency: 1 issue/year

Annals of Clinical Microbiology and Antimicrobials, published by BMC, is a leading open-access journal that has been fostering scientific discourse in the fields of microbiology and infectious diseases since its inception in 2002. With an established reputation for excellence, this journal is positioned in the prestigious Q1 category across multiple disciplines, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology as of 2023. This journal serves as a vital platform for researchers, healthcare professionals, and students, promoting the latest advancements in clinical microbiology and antimicrobial research. Access to its invaluable content is open to all, reflecting the commitment to disseminate knowledge universally. The Annals of Clinical Microbiology and Antimicrobials is based in the United Kingdom and continues to pave the way for innovation and discussions that shape the future of clinical practices in microbiology.

New Microbes and New Infections

Unveiling the latest breakthroughs in microbiology and infectious diseases.
Publisher: ELSEVIER SCI LTDISSN: Frequency: 6 issues/year

New Microbes and New Infections is an esteemed peer-reviewed journal published by Elsevier Sci Ltd that has been a prominent platform for disseminating groundbreaking research in the fields of Infectious Diseases and Microbiology since its establishment in 2013. With an impressive Open Access model, this journal ensures that vital research findings are readily accessible to researchers, healthcare professionals, and academics worldwide. Positioned in the Q2 category for Infectious Diseases and Q3 for Microbiology in 2023, it reaches a significant global audience, as demonstrated by its high Scopus rankings—#44 out of 344 in Medicine: Infectious Diseases, and #34 out of 182 in Immunology and Microbiology. The journal aims to inspire new ideas and foster collaborations by publishing high-quality research focused on novel microbes and infections, thus playing a crucial role in advancing science and public health in an era where understanding infectious agents is more vital than ever.

Current Infectious Disease Reports

Connecting Scholars to the Pulse of Infectious Disease Trends
Publisher: SPRINGERISSN: 1523-3847Frequency: 12 issues/year

Current Infectious Disease Reports, published by SPRINGER, is a leading journal dedicated to advancing knowledge in the field of infectious diseases. With an ISSN of 1523-3847 and an E-ISSN of 1534-3146, this peer-reviewed journal has established itself as a vital resource for researchers and healthcare professionals since its inception in 1999. The journal's impact in the academic community is underscored by its Q1 ranking in Infectious Diseases for 2023, placing it in the top quartile of influential journals in the field. Furthermore, it holds a respectable position at rank #95 out of 344 in the Scopus database, reflecting its substantial contribution to medicine and public health. While currently not an open access journal, it offers a wealth of articles covering the latest research, case studies, and reviews, making it an indispensable tool for those aiming to stay at the forefront of infectious disease science. As we navigate an era marked by emerging and re-emerging infectious threats, Current Infectious Disease Reports remains committed to providing high-quality, relevant research that supports evidence-based practice and informs future studies globally.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Innovating solutions for infectious disease challenges.
Publisher: ELSEVIER SCI LTDISSN: 1201-9712Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, published by ELSEVIER SCI LTD, stands as a leading platform in the realm of infectious diseases, contributing significantly to the global understanding of this critical field. With an impressive impact factor, the journal maintains a distinguished Q1 ranking across various categories, including Infectious Diseases, Medicine (miscellaneous), and Medical Microbiology, demonstrating its high relevance and influence among contemporary research. Since its inception in 1996, it has embraced an Open Access model, allowing for wider dissemination of essential research findings that can inform public health policies and clinical practices. With a commitment to advancing scientific knowledge, this journal is not only a vital resource for researchers and professionals but also serves as an invaluable educational tool for students interested in the complexities of infectious diseases and their management. For those looking to stay at the forefront of research and innovation in this field, the INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES is an indispensable resource.

JOURNAL OF INFECTION

Connecting Researchers and Clinicians in Infection Science
Publisher: W B SAUNDERS CO LTDISSN: 0163-4453Frequency: 12 issues/year

JOURNAL OF INFECTION is a premier academic publication in the fields of infectious diseases and medical microbiology, published by W B SAUNDERS CO LTD. With a profound impact factor and established since 1979, this journal serves as a crucial resource for researchers, clinicians, and policy-makers seeking to advance knowledge and understanding of infectious processes and their management. The JOURNAL OF INFECTION holds an impressive position in the academic hierarchy as reflected by its Q1 quartile rankings in both Infectious Diseases and Microbiology (medical) for 2023, further underscored by its Scopus rankings: #2 in Medical Microbiology and #5 in Medical Infectious Diseases, placing it in the 98th percentile overall. While the journal does not offer Open Access options, it provides a comprehensive outlet for innovative research, reviews, and clinical insights that drive the field forward. Published from the United Kingdom, it attracts a global readership keen on staying at the forefront of infectious disease research, making it an essential addition to any academic and clinical library.

Biosafety and Health

Uniting disciplines to tackle pressing health challenges.
Publisher: ELSEVIERISSN: 2096-6962Frequency: 6 issues/year

Biosafety and Health is a leading peer-reviewed journal published by ELSEVIER, dedicated to advancing knowledge and practice in the fields of biotechnology, infectious diseases, microbiology, and public health. With an ISSN of 2096-6962 and an E-ISSN of 2590-0536, this Open Access journal has been accessible to the global research community since 2019, fostering collaboration and innovation from its base in the Netherlands. Ranked Q2 in multiple categories according to the latest metrics, including Biotechnology and Microbiology (medical), it stands as a testament to high-quality, impactful research that influences clinical and environmental practices. The journal has achieved substantial recognition in various medical fields, ranking in the 88th percentile for Public Health, Environmental and Occupational Health, and the 78th percentile for Infectious Diseases. Researchers and practitioners seeking to contribute to this evolving domain are encouraged to submit their findings, as the journal aims to promote interdisciplinary dialogue and address pressing global health challenges.